APYX vs PATH
Apyx Medical Inc (APYX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
APYX currently screens at market cap $179.6M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the APYX and PATH stock pages for the full models.
Not investment advice.